Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peppermint Oil for IBS or Functional Abdominal Pain in Children
NCT05799053Phase 3Completed
- Start
- May 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of peppermint oil in irritable bowel syndrome (IBS) and functional abdominal pain syndrome (CAPS) (3 arms). Primary endpoint: Abdominal pain intensity response rate at 8 weeks. Started May 2022; status: completed.
02
Drugs
peppermint oil
03
Conditions
irritable bowel syndrome (IBS)functional abdominal pain syndrome (CAPS)
Beyond the preview
Go deeper on NCT05799053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05799053.